RedHill Expands Gastrointestinal Portfolio With Ferring Drug Rights
Israeli pharma RedHill Biopharma secured exclusive commercialization rights to two FDA-approved GI drugs, Rebyota and Clenpiq, from Ferring Pharmaceuticals.
Israeli pharma RedHill Biopharma secured exclusive commercialization rights to two FDA-approved GI drugs, Rebyota and Clenpiq, from Ferring Pharmaceuticals.